Skip to content
Genetic Analysis
Genetic Analysis
  • Home
  • About us
    • How we work
    • Management
    • Board of Directors
    • Partnerships
  • Products
    • Service Products
      • The GA-map® Dysbiosis Test Lx
      • The GA-map® COVID-19 Fecal Test Kit
    • Lab Products
      • The GA-map® Dysbiosis Lx reagent kit
      • The GA-map® COVID-19 reagent kit
  • News
    • Press Releases
    • News
  • Investors
    • Investor News
      • Press Releases
    • Financial Reports
    • Financial Calendar
    • Share Information
    • Analyst Coverage
    • IPO 2021
    • Corporate Governance
    • Primary Insiders
    • IR Contacts
  • Order
  • Contact us
Genetic Analysis
  • Home
  • About us
    • How we work
    • Management
    • Board of Directors
    • Partnerships
  • Products
    • Service Products
      • The GA-map® Dysbiosis Test Lx
      • The GA-map® COVID-19 Fecal Test Kit
    • Lab Products
      • The GA-map® Dysbiosis Lx reagent kit
      • The GA-map® COVID-19 reagent kit
  • News
    • Press Releases
    • News
  • Investors
    • Investor News
      • Press Releases
    • Financial Reports
    • Financial Calendar
    • Share Information
    • Analyst Coverage
    • IPO 2021
    • Corporate Governance
    • Primary Insiders
    • IR Contacts
  • Order
  • Contact us

genanalysis

Genetic Analysis Co-develops HumGut – The world’s first complete database of reference genomes

2021-09-242021-08-05

Eagle Biosciences Announces Agreement with Genetic Analysis AS for Distribution in North America

2021-09-242021-06-16

Genetic Analysis awarded NOK 16 million to develop microbiome marker to aid treatment of Inflammatory Bowel Disease

2021-09-242021-06-15

Genetic Analysis Joins Microbiome Therapeutics Innovation Group

2021-05-192021-05-04

Interview with GA’s PhD student

2021-05-052021-03-30

Genetic Analysis AS announces that a patent was granted in the US, from family WO2016120494A

2021-07-112021-03-24

Genetic Analysis AS announces that a patent was granted in India, from family WO2012080754A2

2021-07-112021-03-17

The Importance of Scale in Evaluating the Gut Microbiome

2021-05-052021-03-05

Launch of the GA-map COVID-19 Fecal Test.

2021-01-212021-01-20

The GA-map® Dysbiosis Test was used for microbiota determinations of the effects of high intake of cod or salmon

2021-03-242021-01-20
Post navigation
Older posts
Page1 Page2 Next →

Genetic Analysis AS is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Contact

Phone: +47 48 32 16 10
E-mail: info@genetic-analysis.com
Address: Genetic Analysis AS, Kabelgata 8
0580 Oslo, Norway

Open Google Maps
Connect

LinkedIn

Facebook

Twitter

Navigate

Contact Us

Terms of Use

Privacy Policy

© 2021 Genetic Analysis

  • Home
  • About us
    • How we work
    • Management
    • Board of Directors
    • Partnerships
  • Products
    • Service Products
      • The GA-map® Dysbiosis Test Lx
      • The GA-map® COVID-19 Fecal Test Kit
    • Lab Products
      • The GA-map® Dysbiosis Lx reagent kit
      • The GA-map® COVID-19 reagent kit
  • News
    • Press Releases
    • News
  • Investors
    • Investor News
      • Press Releases
    • Financial Reports
    • Financial Calendar
    • Share Information
    • Analyst Coverage
    • IPO 2021
    • Corporate Governance
    • Primary Insiders
    • IR Contacts
  • Order
  • Contact us